Other languages Towa Pharmaceutical Co., Ltd.

Equities

4553

JP3623150004

Delayed Japan Exchange Other stock markets 01:51:10 2024-06-03 am EDT			5-day change	1st Jan Change
2,937 ^JPY	+1.63%		+2.84%	+24.87%

May. 22	Towa Pharmaceutical Co., Ltd. Announces Board and Committee Resignations	CI
Mar. 25	Towa Pharmaceutical Completes Payment for Director Stock Compensation	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Towa Pharmaceutical Co., Ltd. Announces Board and Committee Resignations	May. 22
Final dividend	Mar. 27	FA
Towa Pharmaceutical Completes Payment for Director Stock Compensation	Mar. 25
VIE STYLE, Inc. announced that it has received ¥305 million in funding from Otsuka Holdings Co., Ltd., KAYAC Inc., Taisho Pharmaceutical Holdings Co., Ltd., Towa Pharmaceutical Co., Ltd., PE&HR Co., Ltd., Murata Manufacturing Co., Ltd. and other investors	Mar. 06
Ex-dividend day for interim dividend	23-09-27	FA
Towa Pharmaceutical : FY2023(1st quarter) Summary of Consolidated Financial Results for the Three Months Ended June 30, 2023(Based on Japanese GAAP) (375K/7P)	23-08-10
Towa Pharmaceutical : FY2023(1st quarter) Supplementary Material of Financial Results (1.03M/28P)	23-08-10
Towa Pharmaceutical : Notice of the 67th Ordinary General Meeting of Shareholders （176KB／10P）	23-05-30
Towa Pharmaceutical : FY2022 Supplementary Material of Financial Results (1.2M/42P)	23-05-15
Towa Pharmaceutical : FY2022(4th quarter) Summary of Consolidated Financial Results for the Year Ended March 31, 2023(Based on Japanese GAAP) (616K/10P)	23-05-15
Towa Pharmaceutical : 2023年3月期決算短信〔日本基準〕（連結）	23-05-15
Towa Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-15
Ex-dividend day for final dividend	23-03-29	FA
Chugai and Towa Launch Edirol Tablet for Osteoporosis Treatment	22-12-09
Ex-dividend day for interim dividend	22-09-28	FA
Ex-dividend day for final dividend	22-03-29	FA
Towa Pharmaceutical Co., Ltd. completed the acquisition of Sunsho Pharmaceutical Co., Ltd. from Carlyle Japan Partners III, a fund managed by The Carlyle Group Inc. (NasdaqGS:CG).	22-03-06
TOWA PHARMACEUTICAL : INTEGRATED REPORT 2021	21-12-21
Towa Pharmaceutical Co., Ltd. agreed to acquire Sunsho Pharmaceutical Co., Ltd. from Carlyle Japan Partners III, a fund managed by The Carlyle Group Inc. (NasdaqGS:CG) for ¥47.7 billion.	21-12-16
Chugai - Towa Pharmaceutical Receives Approval for Authorized Generic Version of Chugai's Osteoporosis Agent Edirol	21-12-06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Towa Pharmaceutical Co., Ltd.

Equities

4553

JP3623150004

Other languages

Filters